Home Case Files Batch Release Authorization

Inspection Case File · Case File #01

Batch Release Authorization — We have a PAI in 45 days. I can't prove who authorized this batch release.

Inspection Case File | GMP Decision Type: Batch Release | Regulatory Focus: 21 CFR 211.192 | Case File ID: CW-BR-001

An FDA inspection reconstruction showing the authorization gap, the missing record, and what a complete authorization record looks like.

21 CFR 211.192 21 CFR 211.165 EU GMP Annex 16

The inspector pulled the batch record. Every step was complete. Then they asked: "Who authorized release, and what was the documented justification?"

That question ends careers. Not because the batch was wrong — but because the release decision was never captured as a formal record.

This case file gives you that record.

Section 1 — Inspection Moment

The investigator reviewed the batch record. Then asked a different question.

During a batch release review, an FDA investigator examined the batch record for a released lot. Every test result passed specification. The Certificate of Analysis was complete. The QA signature was present.

The investigator set the batch record aside and asked one question.

FDA Investigator Question

"Who authorized the release of this batch — and what evidence did they review before making that decision?"

The QA manager produced the batch record. It contained everything the quality system was designed to capture. It did not contain what the investigator was asking for.

Section 2 — What Existed

The batch record was complete. Every required document was present.

The documentation produced during the batch release review met every standard requirement for a completed batch record. Nothing was missing from the quality system's perspective.

Records Present in the Batch File

  • Manufacturing record — completed and reviewed
  • In-process test results — all within specification
  • Final product specification results — confirmed passing
  • Certificate of Analysis — issued and signed
  • QA signature — confirming review completion

The batch record documented the outcome of the release decision. It did not document the authorization event itself.

Section 3 — What Did Not Exist

The investigator asked for a record the batch file was not designed to contain.

The investigator's question was not about test results. It was about decision authority. What was requested was not a batch record — it was an authorization record.

No document in the batch file identified the following:

Records That Did Not Exist

  • The individual responsible for the final release authorization decision
  • The specific evidence evaluated before the release decision was made
  • The regulatory standard governing the authorization judgment
  • The moment the authorization decision formally occurred

The Authorization Gap

The batch record documented what was tested and what passed. It did not document who authorized the conclusion that the batch was acceptable for release — or that this authorization was ever a formal decision event.

Section 4 — Regulatory Consequence

When authorization documentation cannot be produced, investigators issue observations.

FDA investigators reviewing batch release decisions are evaluating decision authority — not test results. They expect to find a record that answers three questions: who reviewed the evidence, what evidence was evaluated, and under which regulatory standard the decision was authorized.

When that record does not exist, the decision cannot be verified as a controlled authorization event. The observation that follows is not about the batch. It is about the missing authorization trail.

Typical Form 483 Observation Language

"Failure of the quality unit to document the decision authorizing the release of drug product batches, including the evidence evaluated before approval and the identity of the responsible decision authority."

Remediation Typically Required

  • Retrospective review of batch release decisions for prior 24 months
  • SOP revision requiring documented authorization at point of decision
  • CAPA with effectiveness verification
  • Reinspection commitment

The remediation burden created by a missing authorization record is substantially greater than the effort required to create one at the moment the decision is made.

Section 5 — Decision Defense Record

What a complete authorization record looks like for batch release.

A Decision Defense Record captures the authorization event at the moment it occurs — before the batch record is finalized, before the investigator arrives. It answers the investigator's question before the question is asked.

Decision Defense Record DDR-2024-0847

Batch Release Authorization — Lot 2024-0847

Decision Type Batch Release Authorization
Decision Owner Director of Quality — [Named Individual]
Quality Unit Representative, final disposition authority
Evidence Evaluated
  • Batch production record — reviewed complete
  • In-process testing results — all within specification
  • Final product specification results — confirmed passing
  • Deviations evaluated — none affecting release decision
  • Certificate of Analysis — confirmed and signed
Regulatory Standard 21 CFR 211.192 · 21 CFR 211.165 · EU GMP Annex 16
Authorization Statement The decision owner reviewed the evidence listed above and authorized batch release based on conformance to approved specifications and quality review requirements. No deviations were identified that would prevent release.
Authorization Timestamp Frozen at moment of decision — immutable

Section 6 — Inspection Outcome

When the investigator asks, the record already exists.

With a Decision Defense Record in place, the investigator's question receives an immediate answer. The QA manager does not reconstruct the authorization trail under inspection pressure. The record was created at the moment the decision was made.

FDA Investigator Question

"Who authorized the release of this batch — and what evidence did they review before making that decision?"

Authorization Record — Immediately Available

  • Decision owner identified by name and role
  • Evidence evaluated listed specifically
  • Regulatory standard governing the decision stated
  • Authorization timestamp frozen at moment of decision
  • Authorization statement documents the rationale

The investigator question is resolved with a single document. The decision is not reconstructed. It is produced.

Inspection Case File · $149

Close this authorization gap before inspection.

This case file documents the full batch release authorization scenario — the investigator's question, the missing record, and the complete Decision Defense Record that resolves it.

Full inspection reconstruction
Authorization gap analysis
Complete DDR example with all required fields
Regulatory clause references — 21 CFR 211.192, 211.165

$149 · Immediate access · No account required

Get the Case File → $149

Not sure where your gaps are? Take the free Authorization Assessment →